For: | Cai L, Yu SZ, Zhang ZF. Cytochrome P450 2E1 genetic polymorphism and gastric cancer in Changle, Fujian Province. World J Gastroenterol 2001; 7(6): 792-795 [PMID: 11854903 DOI: 10.3748/wjg.v7.i6.792] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i6/792.htm |
Number | Citing Articles |
1 |
Xin-Han Zhao, Shan-Zhi Gu, Shan-Xi Liu, Bo-Rong Pan. Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues. World Journal of Gastroenterology 2003; 9(4): 665-669 doi: 10.3748/wjg.v9.i4.665
|
2 |
Wenlei Zhuo, Liang Zhang, Yan Wang, Junjun Ling, Bo Zhu, Zhengtang Chen, Masaru Katoh. CYP2E1 RsaI/PstI Polymorphism and Gastric Cancer Susceptibility: Meta-Analyses Based on 24 Case-Control Studies. PLoS ONE 2012; 7(11): e48265 doi: 10.1371/journal.pone.0048265
|
3 |
Jian-Hui Zhang, Yan Li, Rui Wang, Helen Geddert, Wei Guo, Deng-Gui Wen, Zhi-Feng Chen, Li-Zhen Wei, Gang Kuang, Ming He, Li-Wei Zhang, Ming-Li Wu, Shi-Jie Wang. <italic>NQO1</italic> C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World Journal of Gastroenterology 2003; 9(7): 1390-1393 doi: 10.3748/wjg.v9.i7.1390
|
4 |
S. Raimondi, S. Benhamou, C. Coutelle, S. Garte, R. Hayes, L. Kiemeney, P. Lazarus, L. Le Marchand, S. Morita, A. Povey, M. Romkes, A. Zijno, E. Taioli. Association of metabolic gene polymorphisms with alcohol consumption in controls. Biomarkers 2004; 9(2): 180 doi: 10.1080/13547500410001728381
|
5 |
Ying Li, Huan Yang, Jia Cao, Lisa Hartling. Association between Alcohol Consumption and Cancers in the Chinese Population—A Systematic Review and Meta-Analysis. PLoS ONE 2011; 6(4): e18776 doi: 10.1371/journal.pone.0018776
|
6 |
Xi-Mei Chen, Guo-Yu Chen, Zhi-Rong Wang, Feng-Shang Zhu, Xiao-Lei Wang, Xia Zhang. Detection of micrometastasis of gastric carcinoma in peripheral blood circulation. World Journal of Gastroenterology 2004; 10(6): 804-808 doi: 10.3748/wjg.v10.i6.804
|
7 |
Mitsushige Sugimoto, Takahisa Furuta, Naohito Shirai, Chise Kodaira, Masafumi Nishino, Mihoko Yamade, Mutsuhiro Ikuma, Haruhiko Sugimura, Takashi Ishizaki, Akira Hishida. MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese. Life Sciences 2008; 83(7-8): 301 doi: 10.1016/j.lfs.2008.06.022
|
8 |
Wei-cheng You, Jun-Yan Hong, Lian Zhang, Kai-feng Pan, David Pee, Ji-you Li, Jun-ling Ma, Nathaniel Rothman, Neil Caporaso, Joseph F. Fraumeni, Guang-wei Xu, Mitchell H. Gail. Genetic Polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the Risk of Advanced Precancerous Gastric Lesions in a Chinese Population. Cancer Epidemiology, Biomarkers & Prevention 2005; 14(2): 451 doi: 10.1158/1055-9965.EPI-04-0311
|
9 |
Jin-Ying Ning, Guo-Xun Sun, Su Huang, Hong Ma, Ping An, Lin Meng, Shu-Mei Song, Jian Wu, Cheng-Chao Shou. Identification of antigens by monoclonal antibody PD4 and its expression in <italic>Escherichia coli</italic>. World Journal of Gastroenterology 2003; 9(10): 2164-2168 doi: 10.3748/wjg.v9.i10.2164
|
10 |
Hui-Jie Liu, Xiao-Lin Guo, Ming Dong, Lan Wang, Yuan Yuan. Association between pepsinogen C gene polymorphism and genetic predisposition to gastric cancer. World Journal of Gastroenterology 2003; 9(1): 50-53 doi: 10.3748/wjg.v9.i1.50
|
11 |
ATSUKO SHIBATA, JULIE PARSONNET. Cancer Epidemiology and Prevention. 2006; : 707 doi: 10.1093/acprof:oso/9780195149616.003.0037
|
12 |
Bashar Abd Alkadhim Naji, Wijdan Thamir Mahdi. CYP2E1 Polymorphisms and Colorectal Cancer. Research Journal of Pharmacy and Technology 2021; : 3879 doi: 10.52711/0974-360X.2021.00673
|
13 |
Yong Li, Lin Yang, Jian-Tao Cui, Wen-Mei Li, Rui-Fang Guo, You-Yong Lu. Construction of cDNA representational difference analysis based on two cDNA libraries and identification of garlic inducible expression genes in human gastric cancer cells. World Journal of Gastroenterology 2002; 8(2): 208-212 doi: 10.3748/wjg.v8.i2.208
|
14 |
M. SUGIMOTO, T. FURUTA, N. SHIRAI, A. NAKAMURA, M. KAJIMURA, H. SUGIMURA, A. HISHIDA, T. ISHIZAKI. Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 2005; 22(10): 1033 doi: 10.1111/j.1365-2036.2005.02678.x
|
15 |
Ali Delpisheh, Loretta Brabin, Bernard J Brabin. Pregnancy, Smoking and Birth Outcomes. Women's Health 2006; 2(3): 389 doi: 10.2217/17455057.2.3.389
|
16 |
Guo-Yong Hu, Bao-Ping Yu, Wei-Guo Dong, Mu-Qi Li, Jie-Ping Yu, He-Sheng Luo, Zong-Xue Rang. Expression of TFF2 and <italic>Helicobacter pylori</italic> infection in carcinogenesis of gastric mucosa. World Journal of Gastroenterology 2003; 9(5): 910-914 doi: 10.3748/wjg.v9.i5.910
|
17 |
Eric Tzyy Jiann Chong, Chong Cin Lee, Kek Heng Chua, Jitt Aun Chuah, Ping-Chin Lee. RsaI but notDraI polymorphism inCYP2E1gene increases the risk of gastrointestinal cancer in Malaysians: a case–control study. BMJ Open 2014; 4(1): e004109 doi: 10.1136/bmjopen-2013-004109
|
18 |
Jucimara Colombo, Andréa Regina Baptista Rossit, Alaor Caetano, Aldenis Albaneze Borim, Durval Wornrath, Ana Elizabete Silva. <italic>GSTT1</italic>, <italic>GSTM1</italic> and <italic>CYP2E1</italic> genetic polymorphisms in gastric cancer and chronic gastritis in a Brazilian population. World Journal of Gastroenterology 2004; 10(9): 1240-1245 doi: 10.3748/wjg.v10.i9.1240
|
19 |
Lucky Poh Wah Goh, Eric Tzyy Jiann Chong, Kek Heng Chua, Jitt Aun Chuah, Ping-Chin Lee. Significant Genotype Difference in the CYP2E1 PstI Polymorphism of Indigenous Groups in Sabah, Malaysia with Asian and Non-Asian Populations. Asian Pacific Journal of Cancer Prevention 2014; 15(17): 7377 doi: 10.7314/APJCP.2014.15.17.7377
|
20 |
Si-Yuan Wen, Hui Wang, Ou-Jun Sun, Sheng-Qi Wang. Rapid detection of the known SNPs of CYP2C9 using oligonucleotide microarray. World Journal of Gastroenterology 2003; 9(6): 1342-1346 doi: 10.3748/wjg.v9.i6.1342
|
21 |
Jessica H. Hartman, Grover P. Miller, Joel N. Meyer. Toxicological implications of mitochondrial localization of CYP2E1. Toxicology Research 2017; 6(3): 273 doi: 10.1039/C7TX00020K
|
22 |
Peng-Hui Yang, Ya-Nan Wei, Bi-Juan Xiao, Si-Yi Li, Xin-Long Li, Liang-Jun Yang, Hua-Feng Pan, Geng-Xin Chen. Curcumin for gastric cancer: Mechanism prediction <i>via</i> network pharmacology, docking, and <i>in vitro</i> experiments. World Journal of Gastrointestinal Oncology 2024; 16(8): 3635-3650 doi: 10.4251/wjgo.v16.i8.3635
|
23 |
Jian Zhuge, Ye Luo, Ying-Nian Yu. Heterologous expression of human cytochrome P450 2E1 in HepG2 cell line. World Journal of Gastroenterology 2003; 9(12): 2732-2736 doi: 10.3748/wjg.v9.i12.2732
|
24 |
Jian-Hui Zhang, Xia Jin, Yan Li, Rui Wang, Wei Guo, Na Wang, Deng-Gui Wen, Zhi-Feng Chen, Gang Kuang, Li-Zhen Wei, Shi-Jie Wang. Epoxide hydrolase <italic>Tyr</italic>113<italic>His</italic> polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma in population of North China. World Journal of Gastroenterology 2003; 9(12): 2654-2657 doi: 10.3748/wjg.v9.i12.2654
|
25 |
D. Krishnakumar, Umamaheswaran Gurusamy, Kayathri Dhandapani, A. Surendiran, Ruchi Baghel, Ritushree Kukreti, Reneega Gangadhar, Ushakiran Prayaga, S. Manjunath, C. Adithan. Genetic polymorphisms of drug‐metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population. Fundamental & Clinical Pharmacology 2012; 26(2): 295 doi: 10.1111/j.1472-8206.2010.00917.x
|
26 |
MING-XING ZHANG, KAI LIU, FU-GANG WANG, XIAO-WEN WEN, XI-LIN SONG. Association between CYP2E1 polymorphisms and risk of gastric cancer: An updated meta-analysis of 32 case-control studies. Molecular and Clinical Oncology 2016; 4(6): 1031 doi: 10.3892/mco.2016.824
|
27 |
Lin Cai, Zong-Li Zheng, Zuo-Feng Zhang. Risk factors for the gastric cardia cancer: A case-control study in Fujian Province. World Journal of Gastroenterology 2003; 9(2): 214-218 doi: 10.3748/wjg.v9.i2.214
|
28 |
Li-Qun Yang, Shen-Jing Li, Yun-Fei Cao, Xiao-Bo Man, Wei-Feng Yu, Hong-Yang Wang, Meng-Chao Wu. Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases. World Journal of Gastroenterology 2003; 9(2): 359-363 doi: 10.3748/wjg.v9.i2.359
|